tiprankstipranks
Advertisement
Advertisement

COLL Stock Latest News

Collegium Pharmaceutical price target lowered to $48 from $56 at Barclays
The FlyCollegium Pharmaceutical price target lowered to $48 from $56 at Barclays
7d ago
COLL
Collegium Earnings Call: ADHD Growth vs. Pain Headwinds
PremiumCompany Announcements
Collegium Earnings Call: ADHD Growth vs. Pain Headwinds
7d ago
COLL
Collegium Pharmaceutical Launches $50 Million Accelerated Share Buyback
PremiumCompany Announcements
Collegium Pharmaceutical Launches $50 Million Accelerated Share Buyback
13d ago
8K
COLL
Collegium Pharmaceutical Updates Guidance After AZSTARYS Acquisition
PremiumCompany Announcements
Collegium Pharmaceutical Updates Guidance After AZSTARYS Acquisition
20d ago
8K
COLL
Collegium Pharmaceutical Inc. (COLL) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Collegium Pharmaceutical Inc. (COLL) Q2 Earnings Cheat Sheet
22d ago
COLL
Collegium Pharmaceutical to relocate corporate headquarters to Boston
PremiumThe FlyCollegium Pharmaceutical to relocate corporate headquarters to Boston
1M ago
COLL
Collegium Pharma Leans on ADHD to Drive Growth
Premium
Company Announcements
Collegium Pharma Leans on ADHD to Drive Growth
3M ago
COLL
Collegium Shareholders Back Board, Pay and Auditor Choices
Premium
Company Announcements
Collegium Shareholders Back Board, Pay and Auditor Choices
3M ago
8K
COLL
Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition
PremiumCompany Announcements
Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition
4M ago
8K
COLL
Collegium Pharmaceutical Leans Into Growth After Earnings
PremiumCompany Announcements
Collegium Pharmaceutical Leans Into Growth After Earnings
4M ago
COLL
Collegium Reports Strong Q1 Results, Reaffirms 2026 Outlook
PremiumCompany Announcements
Collegium Reports Strong Q1 Results, Reaffirms 2026 Outlook
4M ago
8K
COLL
Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52
PremiumThe Fly
Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52
4M ago
COLL
Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M
PremiumThe FlyCollegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M
4M ago
COLL
Confident Leadership and Attractive Valuation Drive Buy Rating on Collegium (COLL)
Premium
Ratings
Confident Leadership and Attractive Valuation Drive Buy Rating on Collegium (COLL)
4M ago
COLL
Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating
Premium
Ratings
Collegium: Strategic AZSTARYS Acquisition Underpins ADHD Franchise Expansion and Supports Buy Rating
5M ago
COLL
Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise
PremiumCompany Announcements
Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise
5M ago
8K
COLL
Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash
PremiumThe Fly
Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash
5M ago
COLL
Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign
PremiumThe Fly
Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign
6M ago
COLL
Collegium Pharmaceutical Earnings Call: Jornay Leads Growth
PremiumCompany Announcements
Collegium Pharmaceutical Earnings Call: Jornay Leads Growth
6M ago
COLL
Collegium Reports Record 2025 Results and Reaffirms Outlook
PremiumCompany AnnouncementsCollegium Reports Record 2025 Results and Reaffirms Outlook
6M ago
8K
COLL
Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14
Premium
The Fly
Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14
6M ago
COLL
Collegium Pharmaceutical sees FY26 product revenue $805M-$825M
Premium
The Fly
Collegium Pharmaceutical sees FY26 product revenue $805M-$825M
6M ago
COLL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >